Explore the top weight loss programs in the UK, from digital apps to medically supported options, and find the best fit for ...

The list price of Wegovy will be cut in half on January 1, 2027, plummeting from around $1,350 to $675 a month. The cost of ...

Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.

The Danish drugmaker released late-stage data showing that the upcoming injection CagriSema failed to match the weight loss ...

Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...

Novo Nordisk announced Tuesday it will be slashing the list price of its blockbuster GLP-1 medications, Ozempic, Wegovy and Rybelsus, by up to 50 percent beginning next year. Starting on Jan. 1, 2027, ...

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...

The reductions will take effect next January, and both Ozempic and Wegovy will list for $675 a month.